Asterion Raises £355k Funding to Progress Novel Therapies for Hormone Related Diseases
16-May-2006 -
Biofusion plc announced that its portfolio company Asterion Ltd, the Sheffield-based drug development company has raised £355k to progress its novel therapies for hormone-related diseases. Biofusion led the round, investing £250k. The White Rose Technology Seedcorn Fund ("WRTSF"), the venture ...
cytokines
diseases
drug development
+2